- Investor's Business Daily•yesterday
Amgen trumped Regeneron and Sanofi this week as prescriptions of its cholesterol-cutting drug grew.
- PR Newswire•yesterday
THOUSAND OAKS, Calif., April 21, 2017 /PRNewswire/ -- Amgen (AMGN) today announced that it will report its first quarter financial results on Wednesday, April 26, 2017, after the close of the U.S. financial markets. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors.
- Zacks•2 days ago
We expect biotech major Amgen Inc. (AMGN) to beat expectations when it reports first-quarter 2017 results on Apr 26 after the market closes.
AMGN : Summary for Amgen Inc. - Yahoo Finance
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||160.01 x 100|
|Ask||160.40 x 100|
|Day's Range||160.25 - 162.73|
|52 Week Range||133.64 - 184.21|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||15.67|
|Dividend & Yield||4.60 (2.84%)|
|1y Target Est||N/A|